Delivery Order SPE2DB22D9367-SPE2DB25FSZ35
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, issued under firm fixed-price terms with an ultimate completion date of September 4, 2025, represents a specific purchase order executed without set-aside designation. DMS Pharmaceutical Group, registered in the System for Award Management since...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The award, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This firm fixed-price delivery order is scheduled for ultimate completion by September 11, 2025, and was awarded on August 20, 2025, with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,940.55 to DMS Pharmaceutical Group Inc. for Botox 200-unit vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a pharmaceutical supply requirement fulfilled through DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $44,087.00, is to provide BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DLA and DMS Pharmaceutical Group,...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ35Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials, with performance scheduled for completion by September 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities. This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company's IDC with the DLA under the SPE2DB program authorizes the delivery of branded and generic prescription drugs, biologics, and medical consumables across multiple product categories to Department of Defense healthcare sites nationwide. The Botox delivery under this order is consistent with the company's portfolio of specialty pharmaceutical products, which encompasses everything from oncology treatments to specialty injections, reinforcing its position as a trusted provider of specialized medical supplies to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/25/25 |